Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caribou Biosciences Inc (NQ: CRBU )

3.775 +0.015 (+0.40%)
Streaming Delayed Price Updated: 10:04 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 55,598
Open 3.900
Bid (Size) 3.770 (8)
Ask (Size) 3.780 (4)
Prev. Close 3.760
Today's Range 3.720 - 3.900
52wk Range 3.440 - 8.590
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
From Caribou Biosciences, Inc.
Via GlobeNewswire
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
From Caribou Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
-32.23%
-32.23%
1 Month
-25.40%
-25.40%
3 Month
-29.70%
-29.70%
6 Month
-1.18%
-1.18%
1 Year
-10.97%
-10.97%

More News

Read More
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
From Caribou Biosciences, Inc.
Via GlobeNewswire
Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Gold Down Over 1%; ClearOne Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Caribou Biosciences Stock Is Crashing Today
Via The Motley Fool
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Via Talk Markets
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
From Caribou Biosciences, Inc.
Via GlobeNewswire
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
Via The Motley Fool
Caribou Biosciences to Participate in Upcoming Investor Conferences
From Caribou Biosciences, Inc.
Via GlobeNewswire
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
Via The Motley Fool
3 Biotech Stocks You Can Buy and Hold for the Next Decade
Via The Motley Fool
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
From Caribou Biosciences, Inc.
Via GlobeNewswire
3 Gene-Editing Stocks With the Potential to Mint Millionaires
Via InvestorPlace
Exposures Product Safety
Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
From Caribou Biosciences, Inc.
Via GlobeNewswire
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
Via InvestorPlace
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
Via The Motley Fool
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board
From Caribou Biosciences, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.